Okta shares fell 4% in premarket trading after Piper Sandler cut its price target to $95 from $110, citing signs of slowing growth despite the company’s Q3 beat. The firm pointed to weaker expansion in cRPO and subscription revenue as key concerns. While fundamentals exceeded estimates, analysts warned that decelerating momentum could pressure Okta’s near-term outlook.